Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edotecarin in advanced gastric cancer
NCT00087503Phase 2Completed
- Sponsor
- Pfizer
- Start
- Apr 2004
- Primary completion
- Jun 2005
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of edotecarin in gastric cancer (GC), sponsored by Pfizer. Started Apr 2004; status: completed.
02
Drugs
edotecarin
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00087503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00087503.